BackEZZ Life Science Holdings Limited Overview

EZZ Life Science Holdings Limited Intangible Assets

Latest intangible assets for EZZ.AX: $29K.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$28600.00
↑ 1.67% YoYΔ $470.00 vs prior year quarter

Peer trimmed avg / median

Loading

EZZ Life Science Holdings Limited Intangible Assets History

Loading

EZZ Life Science Holdings Limited vs. peers: Intangible Assets Comparison

Loading

EZZ Life Science Holdings Limited Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

EZZ Life Science Holdings Limited (EZZ.AX) FAQ

EZZ Life Science Holdings Limited posts a intangible assets of $29K as of June 2026. That compares with $28K in the prior-year period — up 1.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, EZZ Life Science Holdings Limited's intangible assets was $28K. The latest reading is $29K — a 1.7% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Intangible Assets is one piece of EZZ Life Science Holdings Limited's financial statement story. At $29K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for EZZ.AX's intangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; EZZ Life Science Holdings Limited's other metric pages and overview cover the third.

Judging EZZ Life Science Holdings Limited against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in intangible assets easier to interpret. Start with $29K here, then scan peer and history charts to see if the gap is persistent.